花园生物(300401) - 2018 Q3 - 季度财报

Financial Performance - Operating revenue for the period reached CNY 154,981,647.10, a 100.79% increase year-on-year[8] - Net profit attributable to shareholders increased by 156.06% to CNY 71,601,524.89 compared to the same period last year[8] - Net profit attributable to shareholders after deducting non-recurring gains and losses increased by 146.70% to CNY 64,361,005.89 compared to the same period last year[8] - Basic earnings per share rose by 150.00% to CNY 0.15[8] - The weighted average return on equity increased to 4.96%, up 1.60 percentage points from the previous year[8] - Net profit rose by 117.88% to ¥224,745,423.40, attributed to higher operating revenue and improved product gross margins[18] - Total profit increased by 117.12% to ¥261,421,254.75, driven by rising operating revenue and product gross margin improvements[18] - Total operating revenue for the third quarter reached ¥154,981,647.10, a significant increase from ¥77,187,458.57 in the same period last year, representing a growth of 100.0%[35] - Net profit for the period was ¥71,601,524.89, compared to ¥27,962,875.94 in the previous year, marking an increase of 156.5%[37] - The company reported an operating profit of ¥83,180,263.42, compared to ¥32,109,503.28 in the previous year, an increase of 158.0%[37] - The company reported a total profit of CNY 72,717,004.56 for the third quarter, compared to CNY 22,290,260.30 in the previous year, indicating an increase of approximately 226.5%[41] Assets and Liabilities - Total assets increased by 13.95% to CNY 1,589,478,052.51 compared to the end of the previous year[8] - Net assets attributable to shareholders increased by 15.45% to CNY 1,479,022,558.67 compared to the end of the previous year[8] - The company's total assets reached ¥1,589,478,052.51, up from ¥1,394,834,071.76 at the beginning of the period[30] - The total liabilities decreased slightly to ¥110,455,493.84 from ¥113,716,790.85, indicating improved financial stability[30] - The company's equity attributable to shareholders increased to ¥1,479,022,558.67 from ¥1,281,117,280.91, reflecting strong retained earnings growth[30] - Current liabilities rose to ¥256,913,792.18, up from ¥95,610,638.65, indicating an increase of 168.5%[33] Cash Flow - The net cash flow from operating activities for the year-to-date reached CNY 168,562,463.96, an increase of 36.17%[8] - Cash received from sales and services increased by 29.53% to ¥451,289,019.32 compared to ¥348,395,304.60 in the same period last year[19] - Cash inflow from investment activities surged by 282.54% to ¥1,571,760,036.10, primarily due to an increase in matured financial products[19] - Cash outflow for investment activities increased by 298.54% to ¥1,856,176,478.34, mainly due to higher purchases of financial products[19] - The net cash flow from financing activities showed a significant decline of 783.66%, resulting in a net outflow of ¥31,674,365.18, attributed to increased cash dividends distributed[19] - Cash flow from operating activities generated a net amount of CNY 168,562,463.96, up from CNY 123,786,816.78 year-over-year, reflecting a growth of approximately 36.2%[50] - The company’s cash flow from financing activities resulted in a net outflow of -CNY 31,674,365.18, compared to -CNY 3,584,437.50 in the previous year[52] Research and Development - Research and development expenses surged by 156.92% to ¥16,537,979.55, reflecting increased investment in new products and processes[17] - Research and development expenses for the quarter were ¥7,540,518.64, compared to ¥4,389,041.50 in the previous year, an increase of 71.8%[35] - Research and development expenses increased to CNY 16,537,979.55 from CNY 6,436,910.88, reflecting a rise of about 157.5%[44] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 21,417[11] - The total number of restricted shares increased to 46,202,893, with a total of 28,050,367 shares added during the period[14] Government Subsidies - The company received government subsidies amounting to CNY 7,151,708.22 during the reporting period[9] - Other income increased by 85.05% to ¥7,151,708.22, mainly due to higher government subsidies received[17] Taxation - The company reported a 146.53% increase in taxes and surcharges to ¥7,169,227.21, resulting from increased export tax exemptions[17] - The company paid CNY 50,754,377.09 in taxes during the quarter, compared to CNY 24,738,807.12 in the previous year, indicating an increase of about 105.5%[50]